{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:23:07Z","timestamp":1791847387722,"version":"4.3.4"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,10,30]],"date-time":"2021-10-30T00:00:00Z","timestamp":1635552000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,30]],"date-time":"2021-10-30T00:00:00Z","timestamp":1635552000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Oncol Rep"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s11912-021-01075-1","type":"journal-article","created":{"date-parts":[[2021,10,30]],"date-time":"2021-10-30T04:02:42Z","timestamp":1635566562000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Systematic Reviews and Meta-Analyses of Portal Vein Embolization, Associated Liver Partition and Portal Vein Ligation, and Radiation Lobectomy Outcomes in Hepatocellular Carcinoma Patients"],"prefix":"10.1007","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9841-3839","authenticated-orcid":false,"given":"Resmi A.","family":"Charalel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulce","family":"Askin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Jo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Mitry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyubov","family":"Tmanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Madoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,30]]},"reference":[{"key":"1075_CR1","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/S1072-7515(00)00261-1","volume":"191","author":"J Belghiti","year":"2000","unstructured":"Belghiti J, Hiramatsu K, Benoist S, et al. Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. J Am Coll Surg. 2000;191:38\u201346.","journal-title":"J Am Coll Surg"},{"key":"1075_CR2","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1001\/archsurg.1995.01430020088017","volume":"130","author":"ST Fan","year":"1995","unstructured":"Fan ST, Lai EC, Lo CM, et al. Hospital mortality of major hepatectomy for hepatocellular carcinoma associated with cirrhosis. Arch Surg. 1995;130:198\u2013203.","journal-title":"Arch Surg"},{"key":"1075_CR3","doi-asserted-by":"crossref","unstructured":"Vauthey JN, Chaoui A, Do KA, et al. Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations. Surgery. 2000;127(512\u2013519).","DOI":"10.1067\/msy.2000.105294"},{"key":"1075_CR4","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1097\/00000658-200107000-00010","volume":"234","author":"RT Poon","year":"2001","unstructured":"Poon RT, Fan ST, Lo CM, et al. Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years. Ann Surg. 2001;234:63\u201370.","journal-title":"Ann Surg"},{"key":"1075_CR5","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1097\/00000658-199906000-00005","volume":"229","author":"Y Fong","year":"1999","unstructured":"Fong Y, Sun RL, Jarnagin W, et al. An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg. 1999;229:790\u20139.","journal-title":"Ann Surg"},{"key":"1075_CR6","first-page":"401","volume":"46","author":"M Shimada","year":"1999","unstructured":"Shimada M, Gion T, Hamatsu T, et al. Evaluation of major hepatic resection for small hepatocellular carcinoma. Hepato-Gastroenterology. 1999;46:401\u20136.","journal-title":"Hepato-Gastroenterology."},{"issue":"2","key":"1075_CR7","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1097\/01.SLA.0000048447.16651.7B","volume":"237","author":"O Farges","year":"2003","unstructured":"Farges O, Belghiti J, Kianmanesh R, Regimbeau JM, Santoro R, Vilgrain V, et al. Portal vein embolization before right hepatectomy: prospective clinical trial. Ann Surg. 2003;237(2):208\u201317.","journal-title":"Ann Surg"},{"key":"1075_CR8","doi-asserted-by":"publisher","first-page":"W65","DOI":"10.7326\/0003-4819-151-4-200908180-00136","volume":"151","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med. 2009;151:W65\u201394.","journal-title":"Ann Intern Med"},{"key":"1075_CR9","unstructured":"U.S. Preventive Services Task Force. Guide to clinical preventive services: report of the U.S. Preventive Services Task Force. 1989;24."},{"key":"1075_CR10","doi-asserted-by":"crossref","unstructured":"Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005;5(13).","DOI":"10.1186\/1471-2288-5-13"},{"key":"1075_CR11","doi-asserted-by":"crossref","unstructured":"Wan X, Wang W, Liu J, et al. Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range. BMC Med Res Methodol. 2014;14(135).","DOI":"10.1186\/1471-2288-14-135"},{"key":"1075_CR12","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JPT Higgins","year":"2003","unstructured":"Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557.","journal-title":"BMJ."},{"issue":"4","key":"1075_CR13","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.2307\/2533446","volume":"50","author":"CB Begg","year":"1994","unstructured":"Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50(4):1088\u2013101.","journal-title":"Biometrics."},{"key":"1075_CR14","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629\u201334.","journal-title":"BMJ."},{"issue":"5","key":"1075_CR15","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/j.jhep.2013.06.015","volume":"59","author":"M Vouche","year":"2013","unstructured":"Vouche M, Lewandowski RJ, Atassi R, Memon K, Gates VL, Ryu RK, et al. Radiation lobectomy: time-dependent analysis of future liver remnant volume in unresectable liver cancer as a bridge to resection. J Hepatol. 2013;59(5):1029\u201336.","journal-title":"J Hepatol"},{"issue":"4","key":"1075_CR16","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.surg.2014.12.009","volume":"157","author":"S Pandanaboyana","year":"2015","unstructured":"Pandanaboyana S, Bell R, Hidalgo E, Toogood G, Prasad KR, Bartlett A, Lodge JP. A systematic review and meta-analysis of portal vein ligation versus portal vein embolization for elective liver resection. Surgery. 2015;157(4):690\u20138.","journal-title":"Surgery."},{"issue":"1","key":"1075_CR17","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s13193-013-0279-y","volume":"5","author":"S Vyas","year":"2014","unstructured":"Vyas S, Markar S, Partelli S, Fotheringham T, Low D, Imber C, Malago M, Kocher HM. Portal vein embolization and ligation for extended hepatectomy. Indian J Surg Oncol. 2014;5(1):30\u201342.","journal-title":"Indian J Surg Oncol"},{"issue":"1","key":"1075_CR18","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/SLA.0b013e31815f6e5b","volume":"247","author":"A Abulkhir","year":"2008","unstructured":"Abulkhir A, Limongelli P, Healey AJ, Damrah O, Tait P, Jackson J, Habib N, Jiao LR. Preoperative portal vein embolization for major liver resection: a meta-analysis. Ann Surg. 2008;247(1):49\u201357.","journal-title":"Ann Surg"},{"issue":"3","key":"1075_CR19","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1067\/msy.2002.120234","volume":"131","author":"D Elias","year":"2002","unstructured":"Elias D, Ouellet JF, De Ba\u00e8re T, Lasser P, Roche A. Preoperative selective portal vein embolization before hepatectomy for liver metastases: long-term results and impact on survival. Surgery. 2002;131(3):294\u20139.","journal-title":"Surgery."},{"issue":"5","key":"1075_CR20","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1245\/s10434-008-0269-4","volume":"16","author":"V Pamecha","year":"2009","unstructured":"Pamecha V, Glanzounis G, Davies N, Fusai G, Sharma D, Davidson B. Long-term survival and disease recurrence following portal vein embolisation prior to major hepatectomy for colorectal metastases. Ann Surg Oncol. 2009;16(5):1202\u20137.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"1075_CR21","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.ejso.2016.05.026","volume":"43","author":"GK Glantzounis","year":"2017","unstructured":"Glantzounis GK, Tokidis E, Basourakos SP, Ntzani EE, Lianos GD, Pentheroudakis G. The role of portal vein embolization in the surgical management of primary hepatobiliary cancers. A systematic review. Eur J Surg Oncol. 2017;43(1):32\u201341.","journal-title":"Eur J Surg Oncol"},{"issue":"5","key":"1075_CR22","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1097\/00000658-200011000-00008","volume":"232","author":"D Azoulay","year":"2000","unstructured":"Azoulay D, Castaing D, Krissat J, Smail A, Hargreaves GM, Lemoine A, et al. Percutaneous portal vein embolization increases the feasibility and safety of major liver resection for hepatocellular carcinoma in injured liver. Ann Surg. 2000;232(5):665\u201372.","journal-title":"Ann Surg"},{"issue":"12","key":"1075_CR23","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1097\/01.RVI.0000182183.28547.DC","volume":"16","author":"A Denys","year":"2005","unstructured":"Denys A, Lacombe C, Schneider F, Madoff DC, Doenz F, Qanadli SD, et al. Portal vein embolization with N-butyl cyanoacrylate before partial hepatectomy in patients with hepatocellular carcinoma and underlying cirrhosis or advanced fibrosis. J Vasc Interv Radiol. 2005;16(12):1667\u201374.","journal-title":"J Vasc Interv Radiol"},{"issue":"4","key":"1075_CR24","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.surg.2007.12.006","volume":"143","author":"G Giraudo","year":"2008","unstructured":"Giraudo G, Greget M, Oussoultzoglou E, Rosso E, Bachellier P, Jaeck D. Preoperative contralateral portal vein embolization before major hepatic resection is a safe and efficient procedure: a large single institution experience. Surgery. 2008;143(4):476\u201382.","journal-title":"Surgery."},{"issue":"2","key":"1075_CR25","first-page":"216","volume":"2","author":"W Ji","year":"2003","unstructured":"Ji W, Liu WH, Ma KS, Wang XT, He ZP, Dong JH, et al. Preoperative selective portal vein embolization in two-step hepatectomy for hepatocellular carcinoma in injured livers: a preliminary report. Hepatobiliary and Pancreatic Diseases International. 2003;2(2):216\u201320.","journal-title":"Hepatobiliary and Pancreatic Diseases International"},{"issue":"1","key":"1075_CR26","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s00270-003-0505-z","volume":"27","author":"MJ Kim","year":"2004","unstructured":"Kim MJ, Choo SW, Do YS, Park KB, Han YH, Choo IW, et al. Use of double-occlusion balloon catheter: preoperative portal vein embolization for induction of future remnant liver hypertrophy. Cardiovasc Interv Radiol. 2004;27(1):16\u201320.","journal-title":"Cardiovasc Interv Radiol"},{"issue":"91\u201392","key":"1075_CR27","first-page":"773","volume":"56","author":"A Nanashima","year":"2009","unstructured":"Nanashima A, Sumida Y, Abo T, Nonaka T, Takeshita H, Hidaka S, et al. Clinical significance of portal vein embolization before right hepatectomy. Hepato-Gastroenterology. 2009;56(91\u201392):773\u20137.","journal-title":"Hepato-Gastroenterology."},{"issue":"7","key":"1075_CR28","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1007\/s00268-012-1522-3","volume":"36","author":"RC Siriwardana","year":"2012","unstructured":"Siriwardana RC, Lo CM, Chan SC, Fan ST. Role of portal vein embolization in hepatocellular carcinoma management and its effect on recurrence: a case-control study. World J Surg. 2012;36(7):1640\u20136.","journal-title":"World J Surg"},{"issue":"1","key":"1075_CR29","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s00268-001-0189-y","volume":"26","author":"Y Sugawara","year":"2002","unstructured":"Sugawara Y, Yamamoto J, Higashi H, Yamasaki S, Shimada K, Kosuge T, et al. Preoperative portal embolization in patients with hepatocellular carcinoma. World J Surg. 2002;26(1):105\u201310.","journal-title":"World J Surg"},{"issue":"6","key":"1075_CR30","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1159\/000051967","volume":"17","author":"H Wakabayashi","year":"2000","unstructured":"Wakabayashi H, Yachida S, Maeba T, Maeta H. Indications for portal vein embolization combined with major hepatic resection for advanced-stage hepatocellular carcinomas. A preliminary clinical study. Dig Surg. 2000;17(6):587\u201394.","journal-title":"Dig Surg"},{"issue":"1","key":"1075_CR31","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s00595-004-2882-6","volume":"35","author":"JS Wu","year":"2005","unstructured":"Wu JS, Kubo S, Tanaka H, Shuto T, Takemura S, Tsukamoto T, et al. Type IV collagen 7s domain as a predictor of poor efficacy of portal vein embolization before major hepatectomy. Surg Today. 2005;35(1):41\u20136.","journal-title":"Surg Today"},{"issue":"9","key":"1075_CR32","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1002\/bjs.5341","volume":"93","author":"S Ogata","year":"2006","unstructured":"Ogata S, Belghiti J, Farges O, Varma D, Sibert A, Vilgrain V. Sequential arterial and portal vein embolizations before right hepatectomy in patients with cirrhosis and hepatocellular carcinoma. Br J Surg. 2006;93(9):1091\u20138.","journal-title":"Br J Surg"},{"issue":"5","key":"1075_CR33","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1245\/s10434-010-1423-3","volume":"18","author":"H Yoo","year":"2011","unstructured":"Yoo H, Kim JH, Ko G-Y, Kim KW, Gwon DI, Lee S-G, et al. Sequential transcatheter arterial chemoembolization and portal vein embolization versus portal vein embolization only before major hepatectomy for patients with hepatocellular carcinoma. Ann Surg Oncol. 2011;18(5):1251\u20137.","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"1075_CR34","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1245\/s10434-017-5800-z","volume":"24","author":"S Yamashita","year":"2017","unstructured":"Yamashita S, Sakamoto Y, Yamamoto S, Takemura N, Omichi K, Shinkawa H, et al. Efficacy of preoperative portal vein embolization among patients with hepatocellular carcinoma, biliary tract cancer, and colorectal liver metastases: a comparative study based on single-center experience of 319 cases. Ann Surg Oncol. 2017;24(6):1557\u201368.","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"1075_CR35","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.jamcollsurg.2014.04.022","volume":"219","author":"U Leung","year":"2014","unstructured":"Leung U, Simpson AL, Araujo RL, Gonen M, McAuliffe C, Miga MI, et al. Remnant growth rate after portal vein embolization is a good early predictor of post-hepatectomy liver failure. J Am Coll Surg. 2014;219(4):620\u201330.","journal-title":"J Am Coll Surg"},{"key":"1075_CR36","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1007\/s00268-016-3662-3","volume":"41","author":"TF Ulmer","year":"2017","unstructured":"Ulmer TF, de Jong C, Andert A, et al. ALPPS procedure in insufficient hypertrophy after Portal Vein Embolization (PVE). World J Surg. 2017;41:250\u20137.","journal-title":"World J Surg"},{"issue":"12","key":"1075_CR37","doi-asserted-by":"publisher","first-page":"4046","DOI":"10.1245\/s10434-015-4478-3","volume":"22","author":"N Russolillo","year":"2015","unstructured":"Russolillo N, Ratti F, Vigano L, Langella S, Cipriani F, Aldrighetti L, et al. The influence of aging on hepatic regeneration and early outcome after portal vein occlusion: a case-control study. [erratum appears in Ann Surg Oncol. 2015 Dec;22 Suppl 3:S1614; PMID: 25903427]. Ann Surg Oncol. 2015;22(12):4046\u201351.","journal-title":"Ann Surg Oncol"},{"issue":"140","key":"1075_CR38","first-page":"987","volume":"62","author":"IA Meyer","year":"2015","unstructured":"Meyer IA, Vandoni RE, Alerci M, Raptis DA, Gertsch P. Portal vein embolization followed by liver resection versus liver resection alone: a comparison of liver regeneration dynamics. Hepato-Gastroenterology. 2015;62(140):987\u201391.","journal-title":"Hepato-Gastroenterology."},{"issue":"4","key":"1075_CR39","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.surg.2018.10.023","volume":"165","author":"K Imai","year":"2019","unstructured":"Imai K, Yamashita YI, Nakao Y, Uemura N, Kitamura F, Miyata T, et al. Is disease progression a contraindication for the strategy of portal vein embolization followed by hepatectomy for hepatocellular carcinoma? Surgery. 2019;165(4):696\u2013702.","journal-title":"Surgery."},{"issue":"7","key":"1075_CR40","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.jvir.2018.01.780","volume":"29","author":"J Marti","year":"2018","unstructured":"Marti J, Giacca M, Alshebeeb K, Bahl S, Hua C, Horn JC, et al. Analysis of preoperative portal vein embolization outcomes in patients with hepatocellular carcinoma: a single-center experience. J Vasc Intervent Radiol. 2018;29(7):920\u20136 This study contains the largest number of HCC patients who have undergone PVE.","journal-title":"J Vasc Intervent Radiol"},{"issue":"3","key":"1075_CR41","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.jvir.2018.10.014","volume":"30","author":"EA Takahashi","year":"2019","unstructured":"Takahashi EA, Fleming CJ, Andrews JC. Future liver remnant hypertrophy after portal vein embolization is inversely correlated with intrahepatic tumor burden. J Vasc Intervent Radiol. 2019;30(3):435\u20139.","journal-title":"J Vasc Intervent Radiol."},{"issue":"3","key":"1075_CR42","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.jvir.2018.09.006","volume":"30","author":"SS Wong","year":"2019","unstructured":"Wong SS, Yuen BT, Lee RK, Tsai CS, Cheung YS, Lee KF, et al. Percutaneous portal vein embolization using a simplified Sheathless 18-gauge trocar needle approach: review of efficacy and safety. J Vasc Intervent Radiol. 2019;30(3):440\u20134.","journal-title":"J Vasc Intervent Radiol"},{"issue":"4","key":"1075_CR43","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1245\/s10434-015-5007-0","volume":"23","author":"JG D'Haese","year":"2016","unstructured":"D'Haese JG, Neumann J, Weniger M, Pratschke S, Bjornsson B, Ardiles V, et al. Should ALPPS be used for liver resection in intermediate-stage HCC? Ann Surg Oncol. 2016;23(4):1335\u201343.","journal-title":"Ann Surg Oncol"},{"key":"1075_CR44","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ijsu.2016.04.031","volume":"30","author":"G Vennarecci","year":"2016","unstructured":"Vennarecci G, Grazi GL, Sperduti I, Busi Rizzi E, Felli E, Antonini M, et al. ALPPS for primary and secondary liver tumors. Int J Surg. 2016;30:38\u201344.","journal-title":"Int J Surg"},{"issue":"7","key":"1075_CR45","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.jpedsurg.2014.10.019","volume":"50","author":"JC Wiederkehr","year":"2015","unstructured":"Wiederkehr JC, Avilla SG, Mattos E, Coelho IM, Ledesma JA, Conceicao AF, et al. Associating liver partition with portal vein ligation and staged hepatectomy (ALPPS) for the treatment of liver tumors in children. J Pediatr Surg. 2015;50(7):1227\u201331.","journal-title":"J Pediatr Surg"},{"issue":"38","key":"1075_CR46","doi-asserted-by":"publisher","first-page":"e17182","DOI":"10.1097\/MD.0000000000017182","volume":"98","author":"C Peng","year":"2019","unstructured":"Peng C, Li C, Liu C, Wen T, Yang J, Li B, et al. The outcome of the HCC patients underwent ALPPS: retrospective study. Medicine. 2019;98(38):e17182 This study contains the largest number of HCC patients who have undergone ALPPS that was published within the last three years.","journal-title":"Medicine"},{"issue":"7","key":"1075_CR47","doi-asserted-by":"publisher","first-page":"e0181488","DOI":"10.1371\/journal.pone.0181488","volume":"12","author":"J Goebel","year":"2017","unstructured":"Goebel J, Sulke M, Lazik-Palm A, Goebel T, Dechene A, Bellendorf A, et al. Factors associated with contralateral liver hypertrophy after unilateral radioembolization for hepatocellular carcinoma. PLoS ONE [Electronic Resource]. 2017;12(7):e0181488 This study contains the largest number of HCC patients who have undergone radiation lobectomy.","journal-title":"PLoS ONE [Electronic Resource]"},{"issue":"3","key":"1075_CR48","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1007\/s00259-017-3845-7","volume":"45","author":"X Palard","year":"2018","unstructured":"Palard X, Edeline J, Rolland Y, Le Sourd S, Pracht M, Laffont S, et al. Dosimetric parameters predicting contralateral liver hypertrophy after unilobar radioembolization of hepatocellular carcinoma. Eur J Nucl Med Mol Imaging. 2018;45(3):392\u2013401.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"1075_CR49","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.surg.2017.11.020","volume":"163","author":"ST Orcutt","year":"2018","unstructured":"Orcutt ST, Abuodeh Y, Naghavi A, et al. Kinetic analysis of contralateral liver hypertrophy after radioembolization of primary and metastatic liver tumors. Surgery. 2018;163(5):1020\u20137.","journal-title":"Surgery."}],"container-title":["Current Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-021-01075-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11912-021-01075-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-021-01075-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T08:49:28Z","timestamp":1666774168000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11912-021-01075-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,30]]},"references-count":49,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["1075"],"URL":"https:\/\/doi.org\/10.1007\/s11912-021-01075-1","relation":{},"ISSN":["1523-3790","1534-6269"],"issn-type":[{"value":"1523-3790","type":"print"},{"value":"1534-6269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,30]]},"assertion":[{"value":"31 March 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Resmi A. Charalel receives research support from GE, administered by the AUR (GERRAF), SIR Foundation and the FDA through the Medical Device Innovation Consortium as well as speaker honoraria in 2019 from SIRTex Medical and the American College of Surgery. Jeffrey Sung, Gulce Askin, Jonathan Jo, Maria Mitry, Caroline Chung, and Lyubov Tmanova declare no conflict of interest. David C. Madoff serves on the advisory board for Quantum Surgical and is a consultant for Boston Scientific, GE Healthcare, Guerbet, Johnson & Johnson, Merck, Siemens Medical Solutions, and SIRTEX.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by the authors","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"135"}}